LOXO ONCOLOGY INC FDA Approval NDA 213246

NDA 213246

LOXO ONCOLOGY INC

FDA Drug Application

Application #213246

Documents

Label2020-05-08
Letter2020-05-11
Review2020-08-07
Letter2021-02-01
Label2021-02-01
Letter2022-09-22
Letter2022-09-22
Label2022-09-28
Label2022-09-28

Application Sponsors

NDA 213246LOXO ONCOLOGY INC

Marketing Status

Prescription001
Prescription002

Application Products

001CAPSULE;ORAL40MG2RETEVMOSELPERCATINIB
002CAPSULE;ORAL80MG2RETEVMOSELPERCATINIB

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2020-05-08PRIORITY
LABELING; LabelingSUPPL2AP2021-01-28STANDARD
EFFICACY; EfficacySUPPL7AP2022-09-21STANDARD
EFFICACY; EfficacySUPPL8AP2022-09-21PRIORITY

Submissions Property Types

ORIG1Null30
SUPPL2Null7
SUPPL7Null15
SUPPL8Null7

CDER Filings

LOXO ONCOLOGY INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213246
            [companyName] => LOXO ONCOLOGY INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RETEVMO","activeIngredients":"SELPERCATINIB","strength":"40MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"No"},{"drugName":"RETEVMO","activeIngredients":"SELPERCATINIB","strength":"80MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"05\/08\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213246s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"05\/08\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/213246s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/213246Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2020\\\/213246Orig1s000TOC.cfm\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2020-05-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.